PDL BioPharma Inc. Stock
PDL BioPharma Inc. Stock
With 1 Buy predictions and 2 Sell predictions the community is currently undecided on PDL BioPharma Inc..
Our community identified positive and negative aspects for PDL BioPharma Inc. stock for the coming years. 1 users see the criterium "Management" as a plus for the PDL BioPharma Inc. stock. On the other hand our users think that "Market Position" could be a problem in the future.
Pros and Cons of PDL BioPharma Inc. in the next few years
Pros
1
Capable Management
1
Differentiated customer and product portfolio
1
Revenue growth >5% per year expected
Cons
1
Below average Marketposition
1
EBIT decline/stagnation expected
1
Few uniques
Performance of PDL BioPharma Inc. vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| PDL BioPharma Inc. | - | - | - | - | - | - | - |
| Flexion Therapeutics Inc. | -2.140% | -14.907% | -27.128% | -15.432% | -23.464% | - | - |
| Aravive, Inc. | -0.820% | -15.596% | -23.967% | -46.199% | -14.019% | - | - |
| Corvus Pharmaceuticals Inc | -2.420% | -6.202% | -3.200% | 24.742% | -19.868% | -71.462% | -81.195% |